Published in CMAJ on May 01, 2001
Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ (2006) 1.27
Differences in access to coronary care unit among patients with acute myocardial infarction in Rome: old, ill, and poor people hold the burden of inefficiency. BMC Health Serv Res (2004) 0.91
ST Elevation Myocardial Infarction in the elderly. J Geriatr Cardiol (2012) 0.87
Thrombolytics in elderly patients: a triumph of hope over experience? CMAJ (2001) 0.85
Treatment choices in elderly patients with ST: elevation myocardial infarction-insights from the Vital Heart Response registry. Open Heart (2015) 0.78
Acute myocardial infarction: quality of care in rural Alberta. Can Fam Physician (2006) 0.77
The use of cholesterol-lowering medications after coronary revascularization. CMAJ (2003) 0.76
Is Intra-Aortic Balloon Pump Counterpulsation Sufficient to Treat Patients in Cardiogenic Shock, Undergoing Primary Percutaneous Coronary Intervention. Cardiol Res (2015) 0.75
Disparities in a provision of in-hospital post-arrest interventions for out-of-hospital cardiac arrest (OHCA) in the elderly population-protocol for a systematic review. Syst Rev (2016) 0.75
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
The risk of determining risk with multivariable models. Ann Intern Med (1993) 6.45
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation (2000) 4.06
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med (1993) 3.75
The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group. CMAJ (1998) 3.30
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med (1990) 2.48
Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA (1992) 2.45
Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA (1997) 1.99
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) 1.81
Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. Arch Intern Med (1994) 1.80
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med (1997) 1.58
A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days. The I.S.A.M. Study Group. N Engl J Med (1986) 1.57
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA (1991) 1.50
Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med (1996) 1.31
Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group. Lancet (1988) 1.25
Canadian Consensus Conference on Coronary Thrombolysis--1994 update. Can J Cardiol (1994) 1.02
Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study. Arch Intern Med (1997) 0.92
Recent trends in hospital mortality of acute myocardial infarction--the Worcester Heart Attack Study. Have improvements been realized for all age groups? Arch Intern Med (1994) 0.83
Canadian Consensus Conference on Coronary Thrombolysis--1994 recommendations. National Health Research and Development Program. Can J Cardiol (1994) 0.81
Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA (1998) 4.44
Persistence of use of lipid-lowering medications: a cross-national study. JAMA (1998) 4.15
Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med (1979) 4.04
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA (1997) 3.47
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med (2000) 3.31
The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group. CMAJ (1998) 3.30
Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med (2001) 2.85
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation (1998) 2.72
Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation (1999) 2.38
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol (1999) 2.14
Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study. J Am Coll Cardiol (1999) 2.13
Depression and 1-year prognosis in unstable angina. Arch Intern Med (2000) 2.13
The risks and costs of multiple-generic substitution of topiramate. Neurology (2009) 2.07
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
The Galway Study of Panic Disorder. III. Outcome at 5 to 6 years. Br J Psychiatry (1996) 1.96
A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation (1990) 1.93
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation (2001) 1.83
Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals. Arch Intern Med (1994) 1.80
Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med (1981) 1.71
The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics (1998) 1.60
Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol (1991) 1.56
Antithrombotic agents in coronary artery disease. Chest (2001) 1.53
A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial). Eur Heart J (2000) 1.51
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J (2002) 1.50
Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol (1992) 1.48
Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf (2007) 1.44
Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Am J Cardiol (1991) 1.41
Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor. Thromb Haemost (1999) 1.39
Comparison of efficacy and cost among lipid-lowering agents in patients with primary hypercholesterolemia. Can J Cardiol (1998) 1.39
Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab (2008) 1.37
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J (2001) 1.37
Usefulness of probucol in treating primary hypercholesterolemia. Can Med Assoc J (1980) 1.27
Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction. J Am Coll Cardiol (1985) 1.24
Predictors of long-term persistence on statins in a subsidized clinical population. Value Health (2006) 1.22
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation (1999) 1.19
Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics (1999) 1.18
Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet (1997) 1.17
Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med (1977) 1.16
Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia. Arch Intern Med (1977) 1.14
Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study. Clin Invest Med (2001) 1.12
Community health profile of Windsor, Ontario, Canada: anatomy of a Great Lakes area of concern. Environ Health Perspect (2001) 1.11
Left main stenting-as a bridge to surgery-for acute type A aortic dissection and anterior myocardial infarction. Catheter Cardiovasc Interv (2000) 1.09
Diagnosis and management of heart failure. Canadian Cardiovascular Society. Can J Cardiol (1994) 1.08
Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol (1990) 1.08
Physicians' attitudes to the pharmacological treatment of patients with stable angina pectoris. QJM (2005) 1.07
Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther (2005) 1.07
Predictors of persistence of use of the novel antidiabetic agent acarbose. Arch Intern Med (2001) 1.05
Pulsed doppler echocardiographic study of mitral stenosis. Circulation (1980) 1.05
Shanghai trial of nifedipine in the elderly (STONE). J Hypertens (1996) 1.04
Clinical and angiographic factors associated with progression of coronary artery disease. J Am Coll Cardiol (1984) 1.03
Differences in persistence among different weekly oral bisphosphonate medications. Osteoporos Int (2008) 1.02
Initial health screening results for Karen refugees: a retrospective review. Can Commun Dis Rep (2007) 1.02
Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients. Am J Cardiol (1984) 1.01
Are patients suffering from stable angina receiving optimal medical treatment? QJM (2001) 1.01
Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum (2000) 1.01
Long-term prognosis of patients with variant angina. Circulation (1987) 1.01
Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation (1992) 1.00
Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures. Osteoporos Int (2007) 0.99
Unstable angina and progression of coronary atherosclerosis. N Engl J Med (1983) 0.97
Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol (1983) 0.97
Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina. Circulation (1979) 0.97
Prognostic significance of progression of coronary artery disease. Am J Cardiol (1985) 0.96
Clinical characteristics associated with sudden death in patients with variant angina. Circulation (1982) 0.96
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ (1997) 0.96
The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther (2007) 0.95
Autoinhibition in rabbit aortic strips after epinephrine. J Pharmacol Exp Ther (1967) 0.95
Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res (1987) 0.95
Evaluation of the Newton Pen-Pad as a tool for collecting clinical research data at the bed-side. Proc AMIA Annu Fall Symp (1996) 0.94
Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation (1987) 0.94
Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes. Circulation (1995) 0.94
Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect (2005) 0.94
A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol (1985) 0.93
Calcium antagonists. Clinical use in the treatment of angina. Drugs (1983) 0.92
Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporos Int (2014) 0.92
Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects. Circulation (1993) 0.92
Antithrombotic agents in coronary artery disease. Chest (1998) 0.91
Coronary artery spasm during exercise in patients with variant angina. Circulation (1979) 0.91
Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures. Osteoporos Int (2009) 0.91
Cell-to-cell interaction: a mechanism to explain wave-front progression of myocardial necrosis. Am J Physiol (1989) 0.90
Factors influencing the long-term prognosis of treated patients with variant angina. Circulation (1983) 0.90
Effect of the duration of infusion on the disposition of lidocaine in dogs. J Pharmacol Exp Ther (1977) 0.89
Exercise testing in patients with variant angina: results, correlation with clinical and angiographic features and prognostic significance. Circulation (1982) 0.89
Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol (1998) 0.87
Programmed ventricular stimulation in survivors of an acute myocardial infarction. Circulation (1985) 0.87
Early postinfarction ischemia: clinical, angiographic, and prognostic significance. Circulation (1987) 0.86
S-T segment elevation and coronary spasm in response to exercise. Am J Cardiol (1981) 0.86
Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries. Am J Cardiol (1985) 0.86
Angiographic findings after myocardial infarction in patients with previous bypass surgery: explanations for smaller infarcts in this group compared with control patients. Circulation (1985) 0.86
Exercise stress testing in the post-myocardial infarction patient. Am J Cardiol (1983) 0.86
Exposure to allopurinol and the risk of cataract extraction in elderly patients. Arch Ophthalmol (1998) 0.86
Myocardial cell protection : a challenging time for action and a challenging time for clinical research. Circulation (2000) 0.85
Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation (2001) 0.85
Ventricular arrhythmias during ergonovine-induced episodes of variant angina. Am Heart J (1984) 0.85
Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty. Circulation (2000) 0.84
The role of cardiac troponin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndromes. Clin Cardiol (1997) 0.84
Sternal wound infection after heart transplantation: incidence and results with aggressive surgical treatment. Ann Thorac Surg (2001) 0.84